Clinical Excellence and Standards of Care

C5 - Handling the Increasing Prevalence of Drugs Adulterated with Fentanyl

Tuesday, April 12, 2022

11:30 AM – 12:30 PM

Location: Gaylord National, National Harbor 2/3

Workshop Presenter(s)

J Craig Allen, MD, FASAM

Medical Director
Rushford Center
Meriden, Connecticut

Slides
Daniel Rosa, MD

Senior Medical Director
Acacia Network
Bronx, New York

Slides
CA

Christina Arredondo, MD

Medical Director of Behavioral Health
El Rio Community Health Center
Tucson, Arizona

Slides

Street drugs that are adulterated with fentanyl are contributing to an existing epidemic in the US and resulting in significant increases in overdose. The panel discussion will present specific steps that can be taken to remediate this problem, including harm reduction, utilization of fentanyl test strips and public education.

Learning Objectives:

Describe the risks and impacts of street drugs being adulterated with fentanyl.
List three of the four principles for remediating the impact of fentanyl adulterated street drugs.
Describe the use of fentanyl test strips by clinicians and patients
List three harm reduction approaches to remediate the impact of fentanyl adulterating street drugs.